199 related articles for article (PubMed ID: 10022129)
1. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530.
Egan C; Pang A; Durda D; Cheng HC; Wang JH; Fujita DJ
Oncogene; 1999 Feb; 18(5):1227-37. PubMed ID: 10022129
[TBL] [Abstract][Full Text] [Related]
2. Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines.
Bjorge JD; Pang A; Fujita DJ
J Biol Chem; 2000 Dec; 275(52):41439-46. PubMed ID: 11007774
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1, c-Fgr and Lyn.
Agostinis P; Donella-Deana A; Van Hoof C; Cesaro L; Brunati AM; Ruzzene M; Merlevede W; Pinna LA; Goris J
Eur J Biochem; 1996 Mar; 236(2):548-57. PubMed ID: 8612628
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the Src tyrosine kinase and Syp tyrosine phosphatase by their cellular association.
Peng ZY; Cartwright CA
Oncogene; 1995 Nov; 11(10):1955-62. PubMed ID: 7478513
[TBL] [Abstract][Full Text] [Related]
5. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
6. Src kinase regulation by phosphorylation and dephosphorylation.
Roskoski R
Biochem Biophys Res Commun; 2005 May; 331(1):1-14. PubMed ID: 15845350
[TBL] [Abstract][Full Text] [Related]
7. Analysis of pp60c-src tyrosine kinase activity and phosphotyrosyl phosphatase activity in human colon carcinoma and normal human colon mucosal cells.
DeSeau V; Rosen N; Bolen JB
J Cell Biochem; 1987 Oct; 35(2):113-28. PubMed ID: 2448318
[TBL] [Abstract][Full Text] [Related]
8. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T
Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the specificity of bacterially expressed cytoplasmic protein-tyrosine phosphatases SHP and SH-PTP2 towards synthetic phosphopeptide substrates.
Dechert U; Affolter M; Harder KW; Matthews J; Owen P; Clark-Lewis I; Thomas ML; Aebersold R; Jirik FR
Eur J Biochem; 1995 Aug; 231(3):673-81. PubMed ID: 7649167
[TBL] [Abstract][Full Text] [Related]
10. Effective dephosphorylation of Src substrates by SHP-1.
Frank C; Burkhardt C; Imhof D; Ringel J; Zschörnig O; Wieligmann K; Zacharias M; Böhmer FD
J Biol Chem; 2004 Mar; 279(12):11375-83. PubMed ID: 14699166
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the phosphorylation of receptor tyrosine phosphatase-alpha on the Src-independent site tyrosine 789 by reactive oxygen species.
Hao Q; Rutherford SA; Low B; Tang H
Mol Pharmacol; 2006 Jun; 69(6):1938-44. PubMed ID: 16505154
[TBL] [Abstract][Full Text] [Related]
12. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
[TBL] [Abstract][Full Text] [Related]
14. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
Fan G; Aleem S; Yang M; Miller WT; Tonks NK
J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
[TBL] [Abstract][Full Text] [Related]
15. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism.
Walter AO; Peng ZY; Cartwright CA
Oncogene; 1999 Mar; 18(11):1911-20. PubMed ID: 10208413
[TBL] [Abstract][Full Text] [Related]
16. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M
J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatases: mechanisms of catalysis and regulation.
Denu JM; Dixon JE
Curr Opin Chem Biol; 1998 Oct; 2(5):633-41. PubMed ID: 9818190
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of c-SRC activation in human melanocytes: elevated level of protein tyrosine phosphatase activity directed against the carboxy-terminal regulatory tyrosine.
O'Connor TJ; Bjorge JD; Cheng HC; Wang JH; Fujita DJ
Cell Growth Differ; 1995 Feb; 6(2):123-30. PubMed ID: 7538781
[TBL] [Abstract][Full Text] [Related]
19. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
[TBL] [Abstract][Full Text] [Related]
20. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
